In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | | | | | | 41.8 | 37.8 | 34.9 |
Interest income on investments | 32.5 | 21.1 | 27.8 | 27.2 | 20.2 | 12.0 | 7.4 | 5.4 |
Interest income on repurchase agreements | 0.5 | 0.5 | 2.6 | 0.8 | 0.6 | 0.5 | 0.3 | 0.2 |
| 147.8 | 115.0 | 104.9 | 92.1 | 70.8 | 54.2 | 45.4 | 40.5 |
Interest expense: |
| 18.6 | 23.1 | 27.1 | 16.2 | 8.8 | 6.9 | 5.4 | 4.6 |
Net interest income | 129.2 | 91.8 | 77.8 | 75.9 | 62.1 | 47.4 | 40.1 | 35.8 |
Provision for loan losses | 5.8 | 4.2 | 1.9 | 2.3 | 0.9 | 1.6 | 0.5 | 0.9 |
Net interest income after provision for loan losses | 123.5 | 87.6 | 75.9 | 73.6 | 61.2 | 45.8 | 39.6 | 34.9 |
Deposit and loan fees | | | | | | | 1.7 | 1.2 |
Gain on sale of investments, net | | | | | | 0.0 | 0.0 | 0.0 |
Other non-interest income | 32.7 | 36.2 | 23.7 | 20.3 | 20.1 | 15.3 | 8.2 | 6.8 |
Total non-interest income | 32.7 | 36.2 | 23.7 | 20.3 | 20.1 | 15.3 | 9.9 | 8.0 |
Non-interest expenses | 122.5 | 117.4 | 104.5 | 83.7 | 75.3 | 56.3 | 47.1 | 40.6 |
Pre-tax income before non-recurring items | 35.4 | 15.4 | -2.4 | 11.1 | 6.8 | 5.9 | 5.1 | 3.7 |
Non-recurring items | 1.7 | 8.9 | 2.4 | 0.9 | 0.8 | 1.1 | 2.7 | 1.3 |
Pre-tax income | 33.7 | 6.4 | -4.9 | 10.2 | 6.0 | 4.8 | 2.4 | 2.4 |
Income taxes | 8.5 | 1.4 | -1.4 | 1.6 | -2.9 | -0.1 | 0.0 | 0.0 |
Tax rate | 25.3% | 21.6% | 27.8% | 15.5% | | | | |
Net income | 21.7 | 4.1 | -3.5 | 8.6 | 8.9 | 4.9 | 2.4 | 2.4 |
Net margin | 13.9% | 3.3% | -3.5% | 9.2% | 11.0% | 8.1% | 4.9% | 5.7% |
|
Basic EPS | $0.37 | $0.07 | ($0.06) | $0.15 | $0.16 | $0.13 | $0.06 | $0.07 |
Diluted EPS | $0.29 | $0.07 | ($0.06) | $0.15 | $0.15 | $0.12 | $0.06 | $0.07 |
|
Shares outstanding (basic) | 58.9 | 58.9 | 58.8 | 58.4 | 56.9 | 39.3 | 37.8 | 34.2 |
Shares outstanding (diluted) | 76.0 | 58.9 | 58.8 | 59.4 | 58.3 | 39.9 | 38.1 | 34.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |